Pharmacokinetics and Therapeutics of Acute Intramuscular Ziprasidone

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.44, Iss.11, 2005-01, pp. : 1117-1133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ziprasidone: Acute laryngeal dystonia following intramuscular administration: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1151, 2007-01 ,pp. : 30-30

Adis International

Access to resources Recommend Favorite

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

By Daniel David G. Potkin Steven G. Reeves Karen R. Swift Rachel H. Harrigan Edmund P.

Psychopharmacology, Vol. 155, Iss. 2, 2001-05 ,pp. : 128-134

Springer Publishing Company

Access to resources Recommend Favorite

Ziprasidone: Acute dystonia: case report

Reactions Weekly, Vol. 1, Iss. 1163, 2007-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Ziprasidone: Acute dystonia: case report

Reactions Weekly, Vol. 1, Iss. 1051, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

From pharmacokinetics to therapeutics

By Church Martin K. Gillard Michel Sargentini-Maier Maria Laura Poggesi Italo Campbell Alison Benedetti Margherita Strolin

Drug Metabolism Reviews, Vol. 41, Iss. 3, 2009-08 ,pp. : 455-474

Informa Healthcare

Access to resources Recommend Favorite